YAP1 and neuroblastoma: We used the GI-ME-N NB cell line as a representative YAP/TAZ-expressing NB model to test VPF potency—an effective YAP/TAZ inhibitor28, in inducing cell death compared to NB therapeutic agents (retinoic acid—RA, valproic acid—VPA), and other reported blockers of YAP/TAZ activity (dobutamine—Dob, mevastatin—MvS, simvastatin—SvS, cerivastatin—CvS)3,5,25,28.